I have felt it is still possible that, with the current backing of Amarin management, a new appeal could be made to SCOTUS concerning the fraud in the judge DU ninth circuit case, which appeal might lead to a reexamination of judge Du's erroneous decision to invalidate Amarin's high triglyceride patent...and SCOTUS might accept the case for trial.